Explore tweets tagged as #vevyeaccessforall
@OphthTimes
Ophthalmology Times
@OphthTimes
7 months
Sponsored by Harrow. With VEVYE (cyclosporine ophthalmic solution) 0.1% $59* cash-pay option through PhilRx, you can offer your eligible patients an affordable and hassle-free treatment pathway. đŸ”—Learn more: https://t.co/Z0NrMDivqO #ad #vevyeaccessforall #patientfirst #harrow
0
0
0
@OptometryTimes
Optometry Times
@OptometryTimes
7 months
Sponsored by Harrow. With VEVYE (cyclosporine ophthalmic solution) 0.1% $59* cash-pay option through PhilRx, you can offer your eligible patients an affordable and hassle-free treatment pathway. đŸ”—Learn more: https://t.co/b7lp0sm4f4 #ad #vevyeaccessforall #patientfirst #harrow
0
0
0